The company was cleared to receive a $765 million federal loan to make drug ingredients for the U.S. government.
“The news represents a disruption to the system and competitive threat that will likely shift scripts away from the retail channel.”
The $354 million project is designed to reduce the country's reliance on drugs and pharmaceutical ingredients from foreign manufacturers.
In the second major pharmaceutical deal of the year, Eli Lilly will pay about $8 billion for Loxo Oncology.
The $74 billion deal could create the fourth-largest U.S. pharma firm, with a portfolio that includes nine blockbuster drugs.
Drugs such as the diabetes treatment Trulicity "led the company to a strong quarter of volume-driven revenue growth."
The deal would create the world's largest agricultural supplier but Bayer shareholders fear it will be detrimental to its pharmaceutical business
After a relentless pursuit, pharmaceutical firm Mylan pays a large premium to acquire a company that sells over-the-counter drugs.
The companies predict the combined entity would have more than $25 billion in operating cash flow starting in 2018.
